Our study suggests a possible genetic contribution to the neuroendocrine abnormalities observed in ME/CFS,47 implicating HSD11B1 and SCGN, which have roles along the hypothalamic-pituitary-adrenal (HPA) axis. Here, SCGN is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.